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THEME FOR DOCTOR OF MEDICINE THESIS ENTITLED: 
 
 
 
“STUDIES RELATED TO DISEASES AFFECTING THE KIDNEY AND URINARY 
TRACT IN CHILDREN AND THEIR MANAGEMENT” 
 
 
Publications 1-49 represent studies that I have undertaken myself or conjointly over a 34 year 
period to investigate a variety of issues relating to diseases of the kidney and urinary tract in 
children.  The studies were carried out at the Royal Alexandra Hospital for Children, 
Camperdown when I was Clinical Superintendent from 1968 - 1970; The Department of 
Paediatrics, University of Minnesota, Minneapolis, USA when I was Overseas Research 
Fellow of the Post Graduate Foundation in Medicine, University of Sydney, 1970 - 1972,  
then as Staff Physician in Nephrology at the Royal Alexandra Hospital for Children, 
Camperdown, 1972 - 1977, and then Head of that Department at the Hospital until 1995 and 
then as an Honorary Staff Specialist at that hospital. Some of the studies were done conjointly 
with members of the Renal Unit of Royal Prince Alfred Hospital where I hold an Honorary 
appointment and others conjointly with members of the Renal Unit of Prince Henry Hospital, 
Little Bay.  I was appointed Clinical Associate Professor to the Department of Paediatrics and 
Child Health, University of Sydney in 1993. 
 
In 1966 paediatric nephrology was in the early phase of development as a medical 
subspecialty. There was no definitive textbook, the first was published in 1975 (Pediatric 
Nephrology, Ed. Mitchell I. Rubin. Williams and Wilkins.). In the preface to the 2nd edition 
of Renal Disease (Blackwell) in 1967 the editor D.A.K. Black noted that he had included a 
chapter on paediatric aspects which had been planned for the 1st edition in 1962 but ”it could 
not be arranged”. In the chapter on Renal Disease in Children the author, D.Macauly, 
comments that the mortality rate of acute renal failure in children was 50%.      
 
When I joined the resident staff of the Royal Alexandra Hospital for Children in 1966, 
children with renal disease were managed by general paediatricians.  There was no active 
program for the treatment of children with acute or chronic renal failure.  A small number of 
kidney biopsies had been performed by Dr Trefor Morgan who, together with Dr Denis 
Wade, had taught me the technique while I was a resident medical officer at the Royal Prince 
Alfred Hospital in the preceding year.  With the guidance and support of Dr S.E.J. Robertson 
and Dr C. Lee, Honorary Medical Officers, and Dr R.D.K. Reye, Head of the Department of 
Pathology, I began performing kidney biopsies on children at the request of the paediatrician 
in charge.  In the same year, encouraged again by Doctors Robertson and Lee, and by J.C.M. 
Friend and  J. Brown, I introduced peritoneal dialysis for the treatment of children with acute 
renal failure, a technique which I had also been taught by Dr Trefor Morgan whilst I was a 
resident at Royal Prince Alfred Hospital. 
 
Dr Robertson encouraged me to present my experience in percutaneous renal biopsy in 
children at the Annual Meeting of the Australian Paediatric Association in 1968 and this  
study became the first paper I published in relation to disease of the urinary tract in children 
(1).  In 1970 I was granted an Overseas Research Fellowship by the Post Graduate 
Foundation in Medicine, University of Sydney, to enable me to undertake a fellowship in the 
Department of Paediatrics at the University of Minnesota.  I had the great fortune in 
undertaking studies in the new discipline of paediatric nephrology and related research under 
the guidance of Dr A. F. Michael, Dr R.L.Vernier and Dr A. Fish.  I acquired the techniques 
of immunopathology and electron microscopy.  
 
On my return to Australia I established a Department of Nephrology at the Royal Alexandra 
Hospital for Children.  I introduced immunofluorescent and electron microscopic studies for 
the kidney biopsies that I continued to perform and, with the support of Dr R.D.K. Reye, I 
provided the official reports of these studies until 1990. As a result these studies became part 
of the histopathologic service provided by the hospital. I continue to be consulted concerning 
the interpretation of some electron microscopic findings in renal tissue. With the assistance of 
Dr J.D. Harley I set up a laboratory in the Children’s Medical Research Foundation to 
continue and expand the studies I had commenced during my Fellowship.  
 
Establishing a dialysis and transplant program for children with end stage renal disease 
(ESRD) was extremely time consuming. At that time most children with ESRD died.   The 
program was initially established jointly with the Renal Unit at Royal Prince Alfred Hospital 
in 1972 and eventually dialysis facilities were established at the Children’s Hospital using 
predominantly peritoneal dialysis. By 1978 the existence of the Unit was well known in the 
general community and articles appeared in the press. One prompted the late Sir Lorimer 
Dods, the first Professor of Paediatrics in Australia to write to me congratulating me on what 
I had achieved.  He remarked “I have just read with special interest Shaun’s review in the 
SMH of some of your recent achievements in the field of renal failure in infancy and 
childhood and want to offer you my personal congratulations on all that you have achieved 
and are achieving in this area of paediatrics which, in my little world of yesterday, meant 
nothing more than progressive and unrelenting fatal illness”.     
 
Taking part in the development of a relatively new discipline led me to study a number of 
areas. I encouraged trainees to write reports concerning clinical observations and eventually I 
was joined by Fellows whom I encouraged and supported to study a number of different areas 
to ensure that children were being cared for in an environment of strong and open enquiry. 
This led to studies on investigations of chronic renal failure which Dr Elisabeth Hodson 
pursued and studies on urinary tract infection in small children for which Dr Jonathon Craig 
was awarded a PhD. As I had been a contributor and co-author in a number of these studies 
they have been included in my list of publications. As a result of this diversity I have listed 
the publications in 9 sections. The overall theme is to study diseases of the renal tract in 
children and treatments used to understand the processes and ensure the most effective 
treatment. 
 
Some published abstracts of papers presented at scientific meetings have been included to  
clarify invitations I received to prepare reviews and chapters on various subjects and my  
involvement in some conjoint studies. I was author or coauthor of several book chapters, 
reviews, editorials and certain published studies to which I was invited to contribute as a 
result of my primary studies and these I have included as “Derivative References”numbered 
50-76. 
 
SECTION 1: 
 
HISTOLOGY,  IMMUNOCHEMISTRY AND ELECTRON MICROSCOPY OF 
RENAL TISSUE 
 
The first formal studies of the use of kidney biopsy to study kidney disease in childhood were 
published in 1957. I was fortunate to study with Dr Robert Vernier who was the co author of 
one of the papers (77), along with Dr Robert Good and Dr Marilyn Farquhar.  In the  
succeeding 12 years most of the reports dealt with specific applications of kidney biopsy or 
associated complications.  Paper 1 describes my application of the technique for a variety of 
indications rather than to study a particular disease.  The analysis demonstrated the relative 
safety of the technique and was the first step in the process which has led to a refinement of 
the indications of the procedure.This was the first published study of renal biopsy of children 
in Australia. Although Dr R.D.K. Rye reported the histology and reviewed the microscopy 
with me he felt his contribution did not require him to be a co-author. Papers 2-4 relate to 
studies I undertook at the University of Minnesota during my Fellowship. 
 
 Dr Vernier had shown that protein load proteinuria in experimental animals resulted in 
effacement of the foot processes of glomerular epithelial cells (78) and Dr Alfred Michael 
and his group had shown the disappearance of the sialic acid containing polyanion on the 
surface of epithelial cells in aminonucleoside nephrosis (79). Paper 2 describes a study in 
which I demonstrated that protein load proteinuria in the experimental animal also leads to 
diminution of the glomerular polyanion thus suggesting, as has been reported, that these 
changes are a secondary process. I confirmed effacement of epithelial foot processes by 
electron microscopy. The mechanism of proteinuria in nephrotic syndrome with minimal 
glomerular pathology remains uncertain.  
 
I had commenced my studies of glomerular disease reported in Papers 3 and 4 when Dr 
Michael was asked to prepare a review of etiologic agents in immune deposit disease. He 
asked me to undertake the review which he co-authored with Dr Fish and Dr Vernier.  This 
provided immunopathologic, electron microscopic and infectious data related to various 
forms of glomerulonephritis (50).  
 
A syndrome of recurrent macroscopic haematuria in children which seemed relatively benign 
had been known for some time. Deposition of IgA in patients with haematuria had been 
recently described and I studied the findings of 16 children who had the syndrome of 
recurrent macroscopic haematuria and who had had a kidney biopsy. This illustrated that not 
all children with this syndrome have IgA deposition and a small proportion have no evidence  
of deposition of immunoglobulin or complement in the glomeruli. The study also indicated  
that the presence of proteinuria and/or hypertension were the principle adverse prognostic 
indicators which has been repeatedly confirmed since. This paper was cited many times in the 
ensuing 25 years including in the chapter on IgA nephropathy in Pediatric Nephrology  
Holliday, Barratt & Avner, 3rd Ed. Williams &Wilkins,1994. 
 
The association between atopic phenomena and the nephrotic syndrome had been known for 
some time.  While I was studying in Minnesota, a study by Gerber and Paronetto (80), 
suggested IgE was deposited in the glomerulus of children with this condition. This seemed 
inconsistent with the mechanism of action of IgE and I studied kidney biopsies of 9 children 
with this condition as well as 12 children with other forms of proteinuria and found no 
evidence of the deposition of IgE (4). I had used rabbit anti human IgE whereas Drs Gerber 
and Paronetto had used goat anti human IgE. Dr Gerber kindly provided me with a sample of 
his antiserum which I was able to show caused some atypical staining of glomeruli after 
absorption with human IgE suggesting some type of non-specific cross reactivity. My 
involvement in this program of the study of immunologic basis of renal disease led Dr Alfred 
Michael to invite me to be a co-author of a review of immunologic aspects of nephrotic 
syndrome published in Kidney International (52). My study of recurrent haematuria also led to 
an invitation to me from the Medical Journal of Australia to prepare an editorial comment on the 
condition (51).   
 
On return to Australia I continued these studies. In Paper 5 I illustrated the variability of focal 
sclerosing glomerulopathy, both the clinical manifestations and response to treatment.  The 
role of specific therapies in this condition continues to be debated. In my studies of 
immunologic mechanisms of renal disease I had become interested in the alternate pathway 
of complement activation and the role of properdin. Paper 6 illustrated that in the Syndrome 
of Recurrent Macroscopic haematuria the alternate pathway of complement activation 
appeared to be involved although a systemic disturbance of complement could not be 
demonstrated. Paper 7 is a brief letter pointing out that an association between  alpha-1  anti 
trypsin deficiency and membranoproliferative glomerulonephritis reported by Moroz et al 
(81), was almost certainly a chance association.  My continued studies in the area of 
immunologic renal diseases led Dr A.F. Michael to ask me to prepare a chapter on this area 
for a book on immunologic disorders in infants and children (53).  It also led to Dr M. J. 
Robinson, chief physician in the Professorial Medical Unit, University of Melbourne,  to ask 
me to write a chapter on glomerulonephritis and related diseases including hypertension for a 
textbook that he was preparing on Practical Paediatrics (54). 
 
Microangiopathic haemolytic anaemia and thrombocytopenia in children usually suggest the 
diagnosis of haemolytic uraemic syndrome.  The recurrence of the phenomenon in a child  
with membranous nephropathy, an unusual condition in childhood, led me to encourage the 
registrar who was working with me at the time, to prepare a case report describing the 
observation (8). 
 
Dr J. F. Knight studied with me as a Fellow and subsequently trained overseas in paediatric 
nephrology extending the interest in IgA nephropathy that he had gained in my department.  
His paper which I assisted him to prepare, (55), was presented at an International Symposium 
on the condition.   
 
 At this time I was approached by Professor Y. H. Thong, Department of Child Health, 
University of Queensland, to prepare  chapters on Nephritic Syndromes, Acute and Chronic  
Renal Failure and Dialysis and Transplantation for a textbook on paediatric practice that he 
was editing (56). 
 
SECTION 2: 
 
COMPLEMENT STUDIES 
 
Involvement of the complement pathways in the inflammatory process in glomerulonephritis 
remained an interest after I returned from the United States.  In the laboratory I set up a 
variety of assays including assays for the alternate pathway of complement activation (9), and 
C3 nephritic factor and alternate pathway components (10). Assays of the blood of a newborn 
baby whose mother had hypocomplementaemic mesangiocapillary glomerulonephritis showed 
the transient presence of C3 nephritic factor and reduction of complement component C3 (11). 
The baby remained well.  
 
As a result of establishing these methods and assessing use I was invited to take part in the 
evaluation of the pathogenesis of a variety of conditions. Dr Kamath (57) invited me to study 
coeliac disease and I showed evidence of activation of serum complement by gluten 
challenge. Dr Charlesworth (58), (59), (60), invited me to be involved in studies of infectious 
mononucleosis, acute hepatitis and measles and I was able to show both complement 
pathways appeared to be involved in infectious mononucleosis but the classical pathway was 
predominantly involved in resolution of acute hepatitis and measles. Dr Andrew Kemp invited 
me to be involved in the study of yeast opsonisation and phagocytosis as this was thought to 
be a common defect in atopic individuals but this concept was not supported although I 
demonstrated that two of the 17 children with atopic dermatitis had defective alternate 
pathway activity (61).   
 
SECTION 3: 
 
URINARY TRACT INFECTION AND THE ROLE OF VESICOURETERIC REFLUX 
IN RENAL INJURY 
 
Although urinary tract infection had long been recognised as a common problem, in 1970 
there had been few local studies.  As a result, and on the basis of my interest in renal disease 
in children, I was invited by the Post Graduate Committee in Medicine, University of Sydney,  
in 1969 to give a lecture on diagnosis and management of urinary tract infection in children.  
This was published (62) in the Bulletin of the Postgraduate Committee of Medicine, University of 
Sydney.  In the section on treatment I included the suggestion that the combination of 
sulphonamide and trimethoprim, which is now widely used for the treatment and prophylaxis 
of urinary tract infections, would possibly prove to be the therapy of choice in the future.  
There was considerable concern about the the potential toxicity of the combination of  
sulphamethoxazole and trimethoprim and the following year I had the opportunity to observe 
and report the use of the combination for two infants with severe gram negative infections,  
one urinary tract infection and the other meningitis (12). The first infant received treatment 
with conventional dosage but unfortunately had a complex course, was submitted to surgery, 
developed septicaemia and pancytopenia and died.  The second infant had meningitis due to 
E.coli and was failing to respond to conventional treatment. The child was given double the 
usually recommended dose of sulphamethoxazole and trimethoprim and, apart from what was 
considered marginal neutropenia after 5 weeks of therapy, made a complete recovery. This 
was the first time the combination had been used successfully in this way. Although not a 
controlled study such observations can be useful in the initial phases of the introduction of a 
therapy. Debate continues concerning the use of prophylaxis following urinary tract infection 
in children. Methenamine releases formaldehyde in an acid medium which is believed to be 
the mechanism by which it acts as a urinary antiseptic. It has been widely used for urinary 
prophylaxis. It was a general recommendation that during its use that ascorbic acid be 
administered in order to safely decrease the urine Ph and facilitate the action of the drug.   
Monitoring children I was disappointed that this had failed to produce urinary acidification.  I 
then determined that the Vitamin C that was currently marketed was in the form of sodium 
ascorbate which would not be expected to acidify the urine and I reported a personal 
experience that demonstrated urinary acidification could be achieved as long as ascorbic acid, 
which is distasteful to children, was used (13). This observation has been cited in the 
pharmacologic literature.   
 
In 1978 I was invited by the editor of the Australian Paediatric Journal to write an editorial 
comment on an article discussing the localisation of Gram negative urinary infection in 
children and infants (63). The study had involved a relatively invasive process and showed 
that that method had relatively low sensitivity for reflux nephropathy. As a result I suggested 
that the need remained for a non-invasive screening test for reflux nephropathy. This issue 
continues to be discussed as will be mentioned subsequently.   
 
Urinary tract obstruction is frequently associated with adverse outcomes when urinary tract 
infection occurs and is suspected when upper tract dilatation is present. Dr Robert Howman-
Giles and I developed the concept of volume expansion diuretic renal scan using radionuclides 
to accurately determine the presence of obstruction (14). The procedure developed has 
become a standard procedure and the paper is frequently cited in the medical  
and veterinary literature. The report was included in Dr Howman-Giles’s thesis in fulfilment 
of the requirements for the degree of Doctor of Medicine, University of Sydney. 
 
Papers 15 to 21 were based on the study of urinary tract infection which Dr Jonathon Craig 
undertook under my supervision and for which he was awarded a PhD, University of Sydney. 
The studies confirmed the  positive effect of circumcision on reducing the incidence of urinary 
tract infection on boys in the first year of life, demonstrated that micturating 
cystourethrography need not be deferred for a period after a urinary tract infection and  
illustrated the variability in reporting degree of reflux, illustrated the health burden of urinary 
tract infection in children and offered a clear epidemiologic description of symptomatic urine 
infection in preschool children in Australia. The studies also showed that DMSA scintigraphy 
after urinary tract infection is a reliable investigation to demonstrate renal parenchymal  
defects with little inter-observer variation. The studies also demonstrated that children under 6 
months of age with urinary tract infection and high degrees of reflux are at increased risk of 
recurrence. 
 
In 1999 I was invited by the Australian Prescriber to submit an article on childhood urinary 
infections (64).  This paper reviewed the current literature including publications that occurred 
as a result of Dr Craig’s PhD study and pointed out that changes were occurring in the 
approach to the investigation of children with urinary tract infections as a result of the 
availability of new investigations and concerns about the significance of vesicoureteric reflux. 
 This concern was emphasised in a review of data collected by the Australian and New 
Zealand Dialysis and Transplant Registry from 1971 to 1998 which showed no reduction in 
the incidence of end stage renal disease diagnosed as reflux nephropathy in spite of this being 
a period of increasing intervention by antibiotic prophylaxis and surgery (22). These concerns 
were further emphasised in a meta-analysis (65) of randomised controlled trials of antibiotic 
and surgical treatment of vesicoureteric reflux. The conclusion was that it was uncertain 
whether identification and treatment of children with vesicoureteric reflux confers clinically 
important benefit. 
The introduction of antenatal ultrasound resulted necessarily in the identification of any 
dilatation of the urinary tract that was present in the foetus. The immediate response was to 
assume that these children may have vesicoureteric reflux and, in early infancy, subject  them 
to micturating cystourethrogaphy and prescribe prophylactic antibiotic therapy if that 
phenomenon was observed. I designed a randomised double blind placebo controlled trial of 
antibiotic prophylaxis funded by the National Health and Medical Research Council 
(NHMRC). We conducted a randomised double blind placebo controlled trial of prophylaxis in 
infants who have been found to have vesico ureteric reflux because of antenatal ultrasound 
observations or because of a family history. These children had never had a urinary tract 
infection. This study was funded by the NHMRC. In the 3 year follow- up period no difference  
was noted between the two groups (23).  I examined these children at the follow up visits. 
 
On the basis of these studies we are now conducting an NHMRC funded randomised double 
blind placebo controlled trial of antibiotic prophylaxis for children after first urinary tract  
infection, stratified according to whether or not they have vesicoureteric reflux.  I am the 
senior investigator of this study.  It is a multi-centre study involving the Royal Alexandra 
Hospital for Children at Westmead, the Department of Paediatrics and Child Health at the  
Canberra Hospital and the Royal Children’s Hospital, Melbourne.   
 
SECTION 4: 
 
TREATMENT OF RENAL FAILURE, ACUTE AND CHRONIC 
 
Dr John Brown and Dr Allen Oldfield are reported to have used peritoneal dialysis at the 
Royal Alexandra Hospital for Children in the late 1960s as treatment for barbiturate and  
salicylate poisoning. I introduced peritoneal dialysis as a conventional treatment for acute 
renal failure in 1966. An early observation (24) illustrates the need to consider the nature of a 
toxin causing acute renal failure which may not be amenable to removal by dialysis.  
Following my return to Australia after training in paediatric nephrology at the University of 
Minnesota, I was invited by the Postgraduate Committee in Medicine, University of Sydney, to 
give a presentation on acute renal failure in children at a weekend course in paediatrics. This 
was subsequently published (66).  
 
In relation to the treatment of children with renal failure, I established formal procedures for 
their treatment and in 1980 I reported  the outcome of the treatment of the first 35 children 
with end stage renal failure at the Royal Alexandra Hospital for Children. The outcome for 
very young children was positive and it was possible to emphasise that, contrary to certain 
attitudes in Australia at the time, treatment of children with end stage renal failure under the 
age of 5 years of age was appropriate and effective (25). 
 
In 1980 I was invited to give a presentation at a Pan Pacific Symposium on peritoneal dialysis 
in Melbourne to be held under the auspices of Australasian Society of Nephrology, The 
Australian Kidney Foundation and Prince Henry’s Hospital, Melbourne, on Paediatric Dialysis 
in Australia.  I was able to describe the experience with 10 children in end stage renal failure 
being treated with intermittent peritoneal dialysis of whom only one had required transfer to 
haemodialysis and of whom four were attending school full time.  A presentation was made at 
the meeting by Dr S.T. Boen who is credited with having introduced the concept of 
intermittent peritoneal dialysis and in their preface the editors state that the papers presented at 
the symposium were” written by leading investigators from around the world”. My paper is 
published as part of the Proceedings of the Symposium (67). 
 
In 1983 I was invited by the Australian Paediatric Journal to provide an editorial comment on 
an article describing the use of extended therapy for children with end stage renal failure in 
Queensland.  I was able to provide positive comment on the continued introduction of 
integrated treatment for children with end stage renal failure in Australia (68).   
 
Dr Elisabeth Hodson, who is now the Head of the Department of Nephrology at Westmead 
Children’s Hospital, joined me as a Fellow in 1980.  She had an interest in growth retardation 
and renal osteodystrophy in children with chronic renal failure. I encouraged her to pursue this 
area and she spent time working with Dr Richard Evans at the Repatriation General Hospital, 
Concord.  Subsequently two articles were published  in this area (26),(27), which  
importantly demonstrated that while renal osteodystrophy could play a role in growth failure in 
children with chronic renal disease it may not be the major contributor. My role consisted in 
assisting in design of the study , appropriate management of the patients and review of 
manuscripts. 
 
Growth failure was, and continues to be, a major concern for paediatricians caring for children 
with end stage renal failure. As the result of our involvement in a trial of immunosuppressive 
therapy in patients with end stage renal failure which involved an arm 
where patients were treated with cyclosporine alone without corticosteroids (28) we were able 
to observe catch up growth occurring in children in the non steroid arm of the trial (29,30).  I 
had been responsible for the management of the children and recording their clinical findings 
and I reviewed the draft manuscripts.  I supported and took part in the analysis of further data 
on factors affecting growth of children with chronic renal failure (31,32,33). The data for the 
article concerning the estimation of total body nitrogen (33) was reported by Professor Louise 
Baur in her thesis for PhD, University of Sydney. 
 
All those involved in living related donation of non regenerative organs for transplantation 
have concerns for the potential physical, emotional and material adverse events which may 
occur. In 1986 Betty Liounis, a medical student, joined our Unit for an elective term.  She 
illustrated considerable interest in psycho-social aspects of families of children who had had 
renal failure and I encouraged her to undertake a follow-up study of living related kidney 
donors. Typical at the time, this study included principally family donors, but there was one 
emotionally related donor. The study illustrated that donors are able to make a major 
contribution to the life and well-being of the child and that there did not appear to be any 
serious long term complications of the renal donation. Most donors commented that they had 
not been adequately warned of the pain that they may experience from the surgical procedure 
(34). The student conducted all the semistructured interviews and carried out the limited 
physical examinations. I supervised all phases of the study and was directly involved in data 
analysis and preparation of the report. This was the first study of this issue and has been 
widely quoted. The favourable outcomes in relation to the donors renal function and blood 
pressure is similar to the findings reported in a study described in Section 9 paper 47.   
Stimulated by this survey, Dr Hodson prepared a study, The Outcome of Treatment of Renal 
Failure, over the first 16 years in our Unit.  As the result of the analysis it was clear that  
although both dialysis and transplantation are acceptable therapies for children with end stage 
renal failure, successful transplantation provided the best opportunity for satisfactory growth 
and development (35).  
 
As a result of my long term involvement in the treatment of children with end stage renal 
disease and the analyses of outcomes I was invited to prepare an information document (69) as 
a reference for schools with information concerning renal failure and the dialysis treatment of 
renal failure as increasing numbers of children who were being treated with peritoneal and 
haemodialysis were now attending school full time.  
 
SECTION 5 
 
BLOOD PRESSURE IN CHILDREN 
 
The first study of blood pressure in normal children using auscultatory sphygmomanometry 
was published only nine years after Korotkoff reported his observations of the sounds now 
bearing his name in 1905 (82), (83). Various studies of blood pressure in children were 
subsequently published.  In 1977 a formal report of blood pressure levels in a large group of  
normal children in the United States was published (84). It was important to establish normal 
ranges in other groups of children and in 1979 the Australian Kidney Foundation agreed to 
fund a survey of blood pressure levels of children in New South Wales. The study was 
supported by Professor David Tiller, Director of the Renal Unit of Royal Prince Alfred 
Hospital at the time, and statistically studies were undertaken by David L. Jones a medical 
statistician at the New South Wales Department of Health. Centile values were established for 
children aged from 5-13 years. Children’s height and weight were also measured and this gave 
data which strongly suggested that blood pressure was related to size rather than age and that 
obesity also seemed to have an individual effect. The data provided by this study continues to 
be used in standard charts in hospitals. It has been cited on 14 occasions. The publication was 
accompanied by a positive editorial written by Professor Colin I. Johnston from Monash 
University.  As a result of the study and subsequent studies I was invited to prepare an editorial 
comment for the Medical Journal of Australia (70) and to prepare an article for the Indian Journal 
of Paediatrics (71) on drug therapy in childhood hypertension.  I was also invited by the 
National Heart Foundation to provide recommendations for the management of high blood 
pressure in the young in a brochure that the Foundation was preparing concerning the 
management of blood pressure (72). My interest and contribution in the area further led to the 
Journal of Paediatrics and Child Health to invite me to submit an editorial comment on the 
measurement of blood pressure in children in 1997 (73). 
 
 
SECTION 6 
 
NEPHROTIC SYNDROME AND PROTEINURIA 
 
The majority of my studies in relation to nephrotic syndrome blend into studies reported in 
Section 1.  However, in 1977, Dr Carmelo Alfiler from the Philippines joined my Unit as a 
Fellow and demonstrated interest in a number of areas including the possibility that there may 
be genetic markers for the risk of steroid responsive nephrotic syndrome. I encouraged him to 
undertake a study conjointly with the tissue typing laboratory, the Red Cross Blood  
Transfusion Service in Sydney, which resulted in the first observation of an association 
between an HLA-DR antigen (HLA-DRw7) and nephrotic syndrome in spite of the fact that no 
relationship existed between this antigen and atopy (37). My role was to ensure valid case  
selection and to review the draft manuscript. This article has been cited on 45 occasions from 
1981 to 2002 including Chapter 38 on Nephrotic Syndrome Pediatric Nephrology Ed Holliday, 
Barratt & Avner; 3rd Ed, Williams and Wilkins 1994. 
 
As a result of my demonstrated interest in this area, Dr C. S. Pokorny, the Honorary Secretary 
of the Board of Continuing Education of the Royal Australasian College of Physicians, who 
was series editor of Medicine Today, invited me to submit an article on the investigation of the 
child with unexpected proteinuria (74).  This article was subsequently republished by 
permission in the Middle East Edition of Modern Medicine. 
 
SECTION 7 
 
INHERITED METABOLIC DISEASES: (A)CYSTINOSIS,(B) SYNDROME OF 
APPARENT MINERALOCORTICOID EXCESS 
 
7A Cystinosis 
 
Cystinosis is a rare disease which causes multisystem problems and in particular. end stage 
renal failure.  It is due to intracellular accumulation of cystine crystal formation recently 
demonstrated to be due to a defect in membrane transport of cystine. In 1976 Thoene et al 
reported that a variety of aminothiols would reduce the cystine content of cultured fibroblasts 
(85). One of these aminothiols, cysteamine, had been used for other medical purposes and was 
trialled as oral medication in a child with the disease. The trial demonstrated that on the use of 
the compound intracellular cystine content was reduced to normal. Unfortunately the child 
suffered a seizure after one month of treatment and the compound was withdrawn. Prompted 
by this study and the apparent safety when used to treat other conditions I obtained a supply of 
cysteamine hydrochloride and administered it regularly to a child with cystinosis (38). This 
study was done in conjunction with Dr A.C. Pollard from the Department of Chemical 
Pathology at the Adelaide Children’s Hospital  
who measured intracellular cystine concentrations in neutrophil samples I arranged for him to 
receive. We demonstrated that the compound reduced intracellular cystine content to normal 
and during that period no complications occurred and the child volunteered that her 
photophobia (caused by cystine deposition in the cornea) had improved. Over the initial period 
of nine months no adverse affects were noted.  In spite of the initial problems with intolerance 
to a distasteful compound, I vigorously followed a program in attempting to have children with 
cystinosis regularly receive cysteamine orally. Large trials were commenced shortly after this 
study was published which verified safety and benefits although it is now clear that the 
apparent improvement in photophobia was not related directly to the therapy.  
 
The paper has been cited on 15 occasions. I subsequently arranged the establishment of an 
assay for polymorphonuclear leucocyte cystine content in the laboratories for the Centre of 
Kidney Research at the Royal Alexandra Hospital for Children at Westmead (39). The service 
is used nationally to monitor the intracellular content of cystine in children with cystinosis 
being treated with cysteamine. A family I was caring for whose child had cystinosis had a 
second child affected. This child was commenced on cysteamine in early infancy and 
demonstrated normal growth (40).  The child did eventually develop end stage renal failure but 
significantly later than usually occurs and without other systemic manifestations of cystinosis.  
There were many problems involved with the introduction of cysteamine treatment for 
children with cystinosis and I was involved in a number of processes involved in maintaining 
availability. In 2002 I was invited to visit the Department of Paediatrics, Indiana University 
USA, as the William C. and Ruth P. Griffith Visiting Professor and provide a presentation on 
cystinosis. In 1986 I was invited to prepare a summary concerning hereditary and tubular renal 
disorders for Medicine International (75). 
 
7B Syndrome of Apparent Mineralocorticoid Excess 
 
In 1989 I was invited by Professor John Funder from the Medical Research Centre, Prince 
Henry Hospital, Melbourne, to take part in a study of the rare disorder  
Pseudohypoaldosteronism (PHA). I was responsible for the care of a family affected by this 
rare syndrome.  The study tested a hypothesis relating to inappropriate binding of 
mineralocorticoid and glucocorticoid  receptors in PHA and in the Syndrome of Apparent 
Minerlacorticoid Excess. Four children in the family I was caring for were given 
carbenoxolone to inhibit 11 β- hydroxysteroid dehydrogenase. I was responsible for 
prescribing the compound, arranging the collection and analysis of blood and urine samples 
and monitoring the care of the children. The result was marked mineralocorticoid effects with 
antinatriuresis and elevated plasma bicarbonate. This study has demonstrated that the 
phenomena of the syndrome are the result of binding of mineralocorticoid receptors by the 
intrarenal glucocorticoid excess (41). This study had a mjor impact on the understanding of 
this condition and prompted many further studies. It has been cited 100 times.   
 
SECTION 8 
 
HAEMOLYTIC URAEMIC SYNDROME 
 
This syndrome occurs sporadically and in epidemics and in most children is related to  
gastrointestinal infection of a Shiga toxin producing E.coli. It causes acute renal failure which 
may lead to permanent renal damage. I encouraged my Fellow, Dr Alfiler, from the 
Philippines, to review our experience with this condition in 1965 to 1977 and I ultimately 
presented this information to the Australian College of Paediatrics (42). The principal finding 
of the review was that the outcome of the condition could be predicted with reasonable 
accuracy on the basis of the presentation and course of the acute illness. Extra renal 
complications are described in the condition particularly involving the central nervous system 
but in 1989 a child was admitted under our care who had hypoglycemia complicating the 
haemolytic uraemic syndrome (43). The child had diarrhoea associated disease and recovered  
with some impairment of renal function. The child had a marginally elevated serum anylase 
and responded to insulin which suggested that the complication may have been due to 
microvascular disease involving the pancreas. I encouraged Dr Bronwyn Crawford who was 
the Registrar to the unit at that time, to prepare the case report and I supervised the preparation 
of the report. A variety of conditions may be associated with microangiopathic haemolytic 
anaemia and thrombocytopenia. A child was treated in whom the syndrome appeared to 
complicate toxoplasmosis following bone marrow transplantation (44). I was resposible for the 
renal care of the child and assisted in preparation of the report.   
 
 
SECTION 9 
 
ILLUSTRATIVE CASE STUDIES 
 
Over the years I have encouraged medical trainees to analyse unusual clinical incidences.   
The four papers in this section illustrate the outcome of this activity. I directly supervised data 
collection and analysis and preparation of the reports. Dr Howman-Giles, when a Registrar in 
my Unit,  noted that a child developed extreme hypernatraemia while receiving hyperosmolar 
feeds given by gastrostomy. The child had developed appropriate  thirst but this was met by a 
sham oral water intake as he had an oesophagostomy (45). This illustrated the need to carefully 
assess not only intake and output but the significance of biological responses such as thirst.  
 
In 1976 dizygotic twins were seen who had rectal atresia then known as covered anus. Dr 
Albert Mansour was a medical registrar in the Unit at the time and I encouraged him to report 
our findings in the management of these children. He found there had been a previous report of 
the condition occurring in twins who were monozygotic and in that instance only  
one child was reported to be affected. In the children seen in our unit,  kidney biopsies 
(reported by Dr R.D.K. Reye) showed that one of the twins had bilateral renal hypoplasia and 
oligomeganephronia whereas the other had normal kidneys (46). 
 
Wilm’s tumour is widely regarded as a malignancy of childhood which usually responds very 
satisfactorily to treatment. Dr Barrera joined my department as a visiting paediatrician in 1988 
and undertook a long term follow-up study of patients who had had unilateral nephrectomy 
and radiotherapy for Wilm’s tumour. She was able to show that the outcome was good for the 
majority but several patients were hypertensive and two patients had 
reduced renal function. It was suggested that consideration be given to reducing the dose of 
radiation given to children with Stage 1 tumour (47). This study has been cited 21 times in a 
variety of studies related to modifications and outcome of the treatment of Wilm’s tumor and 
studies of the effect of unilateral nephrectomy in man and in experimental animals 
 
Dr Stalens was a medical registrar in my department, and Dr Falk a Fellow, when a child was 
admitted with milky urine. Dr Stalens prepared a report describing the diagnosis of Chyluria in 
this child and the use of lymphoscintigraphy to be a satisfactory and less invasive investigation 
than lymphography to demonstrate the site of the fistula.  Dr Howman-Giles performed the 
radioisotopes studies (48).   
 
In 1987 I was asked to assist in the care of a child with hypertension associated with a 
nephroblastoma. He also had polydypsia. At that time control of hypertension in children 
under these circumstances was difficult and perioperative morbidity was high. As the 
mechanism of the hypertension was ischaemia there was a relative contraindication to 
treatment with angiotensin converting enzyme inhibitors.  However, I made a clinical decision 
to use captopril which was effective and the child underwent an uncomplicated nephrectomy 
and subsequent therapy. His polydipsia abruptly ceased when captopril was started. Dr Graeme 
Suthers, who was registrar to the renal unit at the time, noted evidence that angiotensin had a 
direct effect on the “thirst centre” and I encouraged him to prepare the case report (49).  
 
 
 
In 1985 Professor Judith Whitworth and Professor James Lawrence determined to prepare a 
textbook of renal disease and invited me to prepare a chapter on paediatric nephrology (76).  
The first edition of the book was published in 1987 and the second edition in 1994. The 
chapter I submitted encompasses a broad area of paediatric nephrology commencing with the 
antenatal diagnosis of urinary abnormalities and is illustrated clinically and histologically. It 
concludes with a discussion of urinary incontinence disorders in children.   
 
 I was a foundation member of the International Pediatric Nephrology Association. This year 
the Association honoured me with the award of Honorary Membership “In recognition of 
distinguished contributions to Pediatric Nephrology”. The award was presented at the opening 
session of the 13th Congress of the Association in Adelaide. 
 
